TP53 and hepatocellular carcinoma: Further investigations discovered that Usp5 acts as a novel oncogene and its overexpression promotes the viability, migration, drug resistance and tumorigenicity via alleviating p14ARF-p53 signaling, which contributes to the tumorigenesis of HCC.